Galapagos NV
GLPG
#5176
Rank
S$2.38 B
Marketcap
S$35.50
Share price
0.00%
Change (1 day)
-12.41%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): S$0.71 Billion

According to Galapagos NV's latest financial reports the company's current earnings are S$1.22 Billion. In 2025 the company made an earning of S$0.47 Billion, an increase over its 2024 earnings that were of -S$7.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.71 B50.83%
2025 S$0.47 B-6464.81%
2024 -S$7.4 Million-82.77%
2023 -S$42.94 Million-85.59%
2022 -S$0.3 Billion60.71%
2021 -S$0.19 Billion-60.08%
2020 -S$0.47 Billion-331.44%
2019 S$0.20 B-523.76%
2018 -S$47.37 Million-72.34%
2017 -S$0.18 Billion-329.59%
2016 S$74.59 M-144.3%
2015 -S$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.25 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.41 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.64 B 980.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.80 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$16.83 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.77 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.81 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S$0.17 B-75.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.90 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel